U.S., Dec. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07268079) titled 'Validation of the VIRADIA App for Neurological and Cognitive Diagnostics in Virtual Reality' on Nov. 14.
Brief Summary: The VIRADIA study aims to validate and assess the reliability of a newly developed Virtual Reality (VR) diagnostic platform designed for neurological and cognitive testing. The goal is to determine whether the VR versions of nine commonly used clinical tests measure the same constructs and provide comparable results to their traditional face-to-face or paper-based forms.
The study includes two groups of participants: (1) healthy volunteers and (2) patients with neurological diagnoses. Each participant will complete...